Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 12
Submit an article Journal homepage
892
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma

Tomer M. MarkCenter of Excellence for Lymphoma and Myeloma, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USACorrespondence[email protected]
,
Isaac A. BowmanCenter of Excellence for Lymphoma and Myeloma, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA
,
Adriana C. RossiCenter of Excellence for Lymphoma and Myeloma, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA
,
Manan ShahCenter of Excellence for Lymphoma and Myeloma, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA
,
Melissa RodriguezCenter of Excellence for Lymphoma and Myeloma, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA
,
Ryann QuinnCenter of Excellence for Lymphoma and Myeloma, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA
,
Roger N. PearseCenter of Excellence for Lymphoma and Myeloma, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA
,
Faiza ZafarCenter of Excellence for Lymphoma and Myeloma, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA
,
Karen PekleCenter of Excellence for Lymphoma and Myeloma, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA
,
David JayabalanCenter of Excellence for Lymphoma and Myeloma, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA
,
Scott ElyDepartment of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA
,
Morton ColemanCenter of Excellence for Lymphoma and Myeloma, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA
,
Selina Chen-KiangDepartment of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA
&
Ruben NiesvizkyCenter of Excellence for Lymphoma and Myeloma, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA
 show all
Pages 2842-2849 | Received 14 Oct 2013, Accepted 11 Feb 2014, Published online: 25 Mar 2014

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Asma Bourafai-Aziez, Mohammed Benabderrahmane, Hippolyte Paysant, Louis-Bastien Weiswald, Laurent Poulain, Ludovic Carlier, Delphine Ravault, Marie Jouanne, Gaël Coadou, Hassan Oulyadi, Anne-Sophie Voisin-Chiret, Jana Sopková-de Oliveira Santos & Muriel Sebban. (2021) Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1. Drug Design, Development and Therapy 15, pages 5035-5059.
Read now
Yitav Glantz-Gashai, Tomer Meirson, Eli Reuveni & Abraham O Samson. (2017) Virtual screening for potential inhibitors of Mcl-1 conformations sampled by normal modes, molecular dynamics, and nuclear magnetic resonance. Drug Design, Development and Therapy 11, pages 1803-1813.
Read now
Flora Zagouri, Evangelos Terpos, Efstathios Kastritis & Meletios-Athanasios Dimopoulos. (2015) An update on the use of lenalidomide for the treatment of multiple myeloma. Expert Opinion on Pharmacotherapy 16:12, pages 1865-1877.
Read now

Articles from other publishers (4)

Alessandro Allegra, Chiara Imbesi, Alessandra Bitto & Roberta Ettari. (2021) Drug Repositioning for the Treatment of Hematologic Disease: Limits, Challenges and Future Perspectives. Current Medicinal Chemistry 28:11, pages 2195-2217.
Crossref
Ota Fuchs. (2019) Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs. Cardiovascular & Hematological Disorders-Drug Targets 19:1, pages 51-78.
Crossref
Yehuda Zadik. (2018) Clarithromycin as the empiric antibiotic therapy for medication-related osteonecrosis of the jaw in multiple myeloma patients. Oral Oncology 84, pages 104-105.
Crossref
Hong-xia Xue, Wen-yi Fu, Hua-dong Cui, Li-li Yang, Ning Zhang & Li-juan Zhao. (2015) High-dose thalidomide increases the risk of peripheral neuropathy in the treatment of ankylosing spondylitis. Neural Regeneration Research 10:5, pages 814.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.